(ANSA) - BRUSSELS, JUNE 14 - Ema's position on AstraZeneca has not changed: "The risk-benefit balance remains positive and the vaccine remains authorized for the entire population".
This is what Ema herself specifies in a note referring to the "misinformation" resulting from a misinterpretation of one of their experts published in a newspaper.
(HANDLE).